Return on Tangible Equity (Quarterly)

Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity

BeOne Medicines Ltd. - Sponsored ADR (ONC) had Return on Tangible Equity of 2.55% for the most recently reported fiscal quarter, ending 2025-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$1.32B
Net Income	$94.32M
Cost of Goods Sold	$164.61M
Gross Profit	$1.15B
Operating Expenses	$1.23B
Operating Income	$87.89M
Non-Operating Income/Expense	$11.66M
Pre-Tax Income	$99.55M
Normalized Pre-Tax Income	$99.55M
Income after Taxes	$94.32M
Income from Continuous Operations	$94.32M
Consolidated Net Income/Loss	$94.32M
Normalized Income after Taxes	$94.32M
EBIT	$87.89M
EBITDA	$123.50M
Weighted-Average Shares Outstanding (Basic)	108.32M
Weighted-Average Shares Outstanding (Diluted)	112.56M
Earnings per Share (EPS) (Basic)	$0.87
Earnings per Share (EPS) (Diluted)	$0.84
Balance Sheet Financials
Current Assets	$4.31B
Property, Plant, and Equipment	$1.62B
Long-Term Assets	$1.99B
Total Assets	$6.30B
Current Liabilities	$2.21B
Long-Term Debt	$146.09M
Long-Term Liabilities	$318.08M
Total Liabilities	$2.53B
Common Equity	$3.77B
Tangible Shareholders Equity	$3.71B
Shareholders Equity	$3.77B
Common Shares Outstanding	109.86M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$307.68M
Cash Flow from Investing Activities	$-188.55M
Cash Flow from Financial Activities	$1.25M
Beginning Cash	$2.64B
End Cash	$2.79B
Increase/Decrease in Cash	$147.34M
Stock-Based Compensation	$246.29M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.95
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.04
Debt to Equity Ratio	0.25
Gross Margin	87.49%
Operating Margin	6.68%
EBIT Margin	6.68%
EBITDA Margin	--
Pre-Tax Profit Margin	7.57%
Profit Margin	7.17%
Free Cash Flow	$207.45M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.21
Inventory Turnover	0.33
Receiveable Turnover	1.71
Days Sales in Receivables	52.74
Return on Equity	2.50%
Return on Tangible Equity	2.55%
Return on Assets	1.50%
Return on Investments	2.41%
Book Value Per Share	$34.32
Free Cash Flow per Share	$1.84
Operating Cash Flow per Share	$2.73

Data from Zacks Investment Research, Inc.